Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 29.32% is in line with its 5-year average of 28.39%, near the high end of its 5-year range (-9.87%–37.86%).
1.06% below its 12-month average of 29.63%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 37.86%.
OPERATING MARGIN
29.32%
OPERATING MARGIN AVG TTM
29.63%
OPERATING MARGIN AVG 3Y
27.02%
OPERATING MARGIN AVG 5Y
28.39%
OPERATING MARGIN AVG 10Y
31.66%
OPERATING MARGIN AVG 15Y
31.76%
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-1.06%
CURRENT VS 3Y AVG
+8.50%
CURRENT VS 5Y AVG
+3.28%
CURRENT VS 10Y AVG
-7.38%
CURRENT VS 15Y AVG
-7.69%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
14.90%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+96.78%
vs the sector median at left
Market Cap
$358.00B
Operating Margin
36.17%
TTM Avg
33.84%
3Y Avg
25.86%
5Y Avg
23.98%
Market Cap
$351.56B
Operating Margin
29.16%
TTM Avg
25.33%
3Y Avg
25.67%
5Y Avg
27.00%
Market Cap
$340.79B
Operating Margin
4.82%
TTM Avg
6.16%
3Y Avg
7.45%
5Y Avg
7.80%
Market Cap
$644.12B
Operating Margin
26.81%
TTM Avg
26.05%
3Y Avg
26.47%
5Y Avg
26.06%
Market Cap
$252.62B
Operating Margin
22.77%
TTM Avg
20.95%
3Y Avg
17.06%
5Y Avg
15.08%
Market Cap
$240.97B
Operating Margin
17.69%
TTM Avg
18.04%
3Y Avg
18.11%
5Y Avg
20.54%
Market Cap
$185.26B
Operating Margin
43.10%
TTM Avg
42.74%
3Y Avg
42.98%
5Y Avg
42.70%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AbbVie Inc. (ABBV) | $463.92B | 29.32% | 29.63% | 27.02% | 28.39% |
| Merck & Co., Inc. (MRK)vs › | $358.00B | 36.17% | 33.84% | 25.86% | 23.98% |
| Roche Holding AG (RHHBY)vs › | $351.56B | 29.16% | 25.33% | 25.67% | 27.00% |
| UnitedHealth Group Incorporated (UNH)vs › | $340.79B | 4.82% | 6.16% | 7.45% | 7.80% |
| Johnson & Johnson (JNJ)vs › | $644.12B | 26.81% | 26.05% | 26.47% | 26.06% |
| AstraZeneca PLC (AZN)vs › | $252.62B | 22.77% | 20.95% | 17.06% | 15.08% |
| Thermo Fisher Scientific Inc. (TMO)vs › | $240.97B | 17.69% | 18.04% | 18.11% | 20.54% |
| Amgen Inc. (AMGN)vs › | $203.12B | 33.18% | 25.38% | 28.78% | 30.08% |
| Novo Nordisk A/S (NVO)vs › | $185.26B | 43.10% | 42.74% | 42.98% | 42.70% |
| Gilead Sciences, Inc. (GILD)vs › | $183.36B | 39.74% | 22.76% | 25.11% | 25.54% |
Gross Margin
71.5%
Operating Margin
29.3%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 37.86% |
| 2026-03-31 | 31.56% |
| 2025-12-31 | 34.96% |
| 2025-09-30 | 12.07% |
| 2025-06-30 | 31.73% |
| 2025-03-31 | 27.98% |
| 2024-12-31 | -9.87% |
| 2024-09-30 | 26.49% |
| 2024-06-30 | 27.64% |
| 2024-03-31 | 22.73% |
| 2023-12-31 | 22.34% |
| 2023-09-30 | 16.38% |
| 2023-06-30 | 32.55% |
| 2023-03-31 | 22.64% |
| 2022-12-31 | 36.39% |
| 2022-09-30 | 31.08% |
| 2022-06-30 | 22.59% |
| 2022-03-31 | 34.84% |
| 2021-12-31 | 34.09% |
| 2021-09-30 | 30.02% |
| 2021-06-30 | 31.81% |
| 2021-03-31 | 31.54% |
| 2020-12-31 | 27.08% |
| 2020-09-30 | 25.23% |
| 2020-06-30 | 7.21% |
| 2020-03-31 | 41.80% |
| 2019-12-31 | 45.45% |
| 2019-09-30 | 30.86% |
| 2019-06-30 | 41.19% |
| 2019-03-31 | 38.45% |
| 2018-12-31 | -29.39% |
| 2018-09-30 | 38.36% |
| 2018-06-30 | 33.37% |
| 2018-03-31 | 36.59% |
| 2017-12-31 | 23.18% |
| 2017-09-30 | 38.51% |
| 2017-06-30 | 38.34% |
| 2017-03-31 | 36.82% |
| 2016-12-31 | 34.70% |
| 2016-09-30 | 36.71% |
| 2016-06-30 | 37.00% |
| 2016-03-31 | 38.23% |
| 2015-12-31 | 33.02% |
| 2015-09-30 | 31.71% |
| 2015-06-30 | 33.83% |
| 2015-03-31 | 33.47% |
| 2014-12-31 | -7.61% |
| 2014-09-30 | 19.13% |
| 2014-06-30 | 30.76% |
| 2014-03-31 | 29.61% |
| 2013-12-31 | 30.03% |
| 2013-09-30 | 29.43% |
| 2013-06-30 | 30.97% |
| 2013-03-31 | 30.15% |
| 2012-12-31 | 34.98% |
| 2012-09-30 | 35.40% |
| 2012-06-30 | 31.65% |
| 2012-03-31 | 23.44% |
| 2011-12-31 | 28.35% |
| 2011-09-30 | 1.22% |
| 2011-06-30 | 31.91% |
| 2011-03-31 | 21.16% |
